291 related articles for article (PubMed ID: 24666704)
1. Candidemia surveillance in Iowa: emergence of echinocandin resistance.
Matsumoto E; Boyken L; Tendolkar S; McDanel J; Castanheira M; Pfaller M; Diekema D
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):205-8. PubMed ID: 24666704
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
Thierry G; Morio F; Le Pape P; Gay-Andrieu F; Barre O; Miegeville M
Pathol Biol (Paris); 2011 Feb; 59(1):52-6. PubMed ID: 20832195
[TBL] [Abstract][Full Text] [Related]
5. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
6. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
[TBL] [Abstract][Full Text] [Related]
8. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
[TBL] [Abstract][Full Text] [Related]
9. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals.
Colombo AL; Garnica M; Aranha Camargo LF; Da Cunha CA; Bandeira AC; Borghi D; Campos T; Senna AL; Valias Didier ME; Dias VC; Nucci M
Med Mycol; 2013 Jan; 51(1):38-44. PubMed ID: 22762208
[TBL] [Abstract][Full Text] [Related]
10. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
Al-Baqsami ZF; Ahmad S; Khan Z
Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
12.
Bordallo-Cardona MÁ; Agnelli C; Gómez-Nuñez A; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397068
[TBL] [Abstract][Full Text] [Related]
13. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
[TBL] [Abstract][Full Text] [Related]
14. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
[TBL] [Abstract][Full Text] [Related]
15. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.
Pfaller MA; Castanheira M; Lockhart SR; Ahlquist AM; Messer SA; Jones RN
J Clin Microbiol; 2012 Apr; 50(4):1199-203. PubMed ID: 22278842
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014.
Liu WL; Lai CC; Li MC; Wu CJ; Ko WC; Hung YL; Tang HJ; Hsueh PR
J Microbiol Immunol Infect; 2019 Aug; 52(4):612-619. PubMed ID: 28886952
[TBL] [Abstract][Full Text] [Related]
17. Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.
Arastehfar A; Daneshnia F; Salehi M; Yaşar M; Hoşbul T; Ilkit M; Pan W; Hagen F; Arslan N; Türk-Dağı H; Hilmioğlu-Polat S; Perlin DS; Lass-Flörl C
Mycoses; 2020 Sep; 63(9):911-920. PubMed ID: 32413170
[TBL] [Abstract][Full Text] [Related]
18. Candidaemia in Sweden: a nationwide prospective observational survey.
Ericsson J; Chryssanthou E; Klingspor L; Johansson AG; Ljungman P; Svensson E; Sjölin J
Clin Microbiol Infect; 2013 Apr; 19(4):E218-21. PubMed ID: 23331511
[TBL] [Abstract][Full Text] [Related]
19. Changing epidemiology of candidemia in a medical center in middle Taiwan.
Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
[TBL] [Abstract][Full Text] [Related]
20. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]